Effect of febuxostat on the level of malondialdehyde‐modified low‐density lipoprotein, an oxidative stress marker: A subanalysis of the PRIZE study

BACKGROUND: Febuxostat is a selective xanthine oxidase inhibitor that reportedly exhibits antioxidant properties. We previously performed a multicentre, randomized controlled (PRIZE) study for vascular evaluation under uric acid (UA) control by febuxostat to investigate the progression of carotid le...

Descripción completa

Detalles Bibliográficos
Autores principales: Teragawa, Hiroki, Tanaka, Atsushi, Fujii, Yuichi, Yoshida, Hisako, Ueda, Tomohiro, Nomura, Shuichi, Kadokami, Toshiaki, Koide, Hisashi, Saito, Makoto, Sano, Hiroaki, Bando, Yasuko K., Murohara, Toyoaki, Node, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270262/
https://www.ncbi.nlm.nih.gov/pubmed/36991567
http://dx.doi.org/10.1002/clc.24014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270262/
https://www.ncbi.nlm.nih.gov/pubmed/36991567
http://dx.doi.org/10.1002/clc.24014

Ejemplares similares